IMRX – immuneering corporation - class a (US:NASDAQ)
Stock Stats
News
Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond [Yahoo! Finance]
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond
Immuneering (IMRX) was upgraded by Wall Street Zen from "sell" to "ho
Immuneering CEO Touts 64% 12-Month Survival in Pancreatic Cancer; Phase 3 Launch Nears [Yahoo! Finance]
Form DEFA14A Immuneering Corp
Form DEF 14A Immuneering Corp For: Apr 20
Form 4 Immuneering Corp For: Mar 13 Filed by: Neufeld Leah R
Form 10-K Immuneering Corp For: Dec 31
Form 8-K Immuneering Corp For: Mar 06
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.